EIF2AK3 and Hepatitis: Simultaneous expression of Beclin1 and PERK was not correlated with gender, age, history of hepatitis, history of cirrhosis, tumor size, or degree of differentiation but closely related to clinical stage (P = 0.044) (Table 2).